83948-50-9

Upstream product

• 4797-81-3 N-benzyloxyacetamide 
• 83948-53-2 3-bromopropylamine tert-butylcarbamate 
• 622-33-3 N-benzyloxyamine 
• 83948-52-1 O-Benzyl-N-(p-nitrobenzyloxycarbonyl)hydroxylamine 
• 2687-43-6 O-benzylhydoxylamine hydrochloride 
• 15255-86-4 N-benzyloxycarbonyl-O-benzylhydroxylamine 
• 94136-57-9 3-(tert-butoxycarbonylamino)propanol-O-benzyloxime 
• 24424-99-5 di-tert-butyl dicarbonate 
• 58885-60-2 N-(tert-butoxycarbonyl)-3-aminopropanal 
• 58885-58-8 N-tert-butoxycarbonyl-3-aminopropanol 
• 108-24-7 acetic anhydride 
• 94136-58-0 1-<(tert-butoxycarbonyl)amino>-3-<(benzyloxy)amino>propane 
• 83948-58-7 C₂₃H₂₉N₃O₇ 
• 83948-57-6 C₂₃H₃₀N₂O₅ 

Downstream Products

• 83948-62-3 1-(Acetylamino)-3-<(benzyloxy)amino>propane 
• 83948-61-2 1-Amino-3-propane Hydrochloride 
• 84627-28-1 dichlorhydrate de 1-amino-3-(benzyloxyamino)propane 
• 83948-64-5 1-Amino-3-<(benzyloxy)amino>propane p-Toluenesulfonic Acid Double Salt 
• 132149-18-9 trifluoroacetate de 1-amino-3-(acetylbenzyloxyamino)propane 
• 132149-23-6 N,N'-bis<3-(acetylbenzyloxyamino)propyl>-<4-ethoxy-2,6-pyridine>dicarbamide 
• 132149-20-3 N,N'-bis<3-(acetylbenzyloxyamino)propyl>-<4-pentoxy-2,6-pyridine>dicarbamide 
• 132149-24-7 N,N'-bis<3-(acetylbenzyloxyamino)propyl>-<4-(3-nitrilepropyloxy)-2,6-pyridine>dicarbamide 
• 94136-74-0 N,N'-bis<3-propyl>-2,6-pyridinedicarbamide 
• 35418-52-1 schizokinen 
• 83948-72-5 N-[3-(Acetyl-benzyloxy-amino)-propyl]-2-{[3-(acetyl-benzyloxy-amino)-propylcarbamoyl]-methyl}-2-hydroxy-succinamic acid methyl ester 
• 83948-66-7 N-[3-(Acetyl-benzyloxy-amino)-propyl]-2-(4-{[3-(acetyl-benzyloxy-amino)-propylcarbamoyl]-methyl}-5-oxo-[1,3]dioxolan-4-yl)-acetamide 
• 83948-73-6 N-[3-(Acetyl-benzyloxy-amino)-propyl]-2-{[3-(acetyl-benzyloxy-amino)-propylcarbamoyl]-methyl}-2-hydroxy-succinamic acid isopropyl ester 
• 83948-74-7 2-{[3-(Acetyl-benzyloxy-amino)-propylcarbamoyl]-methyl}-2-hydroxy-succinic acid 1-benzyl ester 4-(4-nitro-phenyl) ester 

Relevant academic research and scientific papers

THE DESIGN OF MAGNETIC RESONANCE CONTRAST AGENTS: NEW IRON (III) DIHYDROXAMATE COMPLEXES

We have prepared a series of dihydroxamates and their iron(III) complexes in view of obtaining new NMR imaging agents.Four new dihydroxamic acid ligands have been synthesized by condensation of 4-substituted-2,6-pyridine dicarboxylic acids with N-aminopro